NCT06775327View on ClinicalTrials.gov

Study to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, & Food Effect of Oral INCB000631 to Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

February 13, 2025

Primary Completion Date

May 28, 2025

Study Completion Date

May 28, 2025

Conditions
Healthy Participants
Interventions
DRUG

INCB000631

Oral; Tablet

DRUG

Placebo

Oral; Tablet

Trial Locations (1)

68502

Celerion, Inc, Lincoln

Sponsors

Lead Sponsor

Incyte Corporation
All Listed Sponsors
lead

Incyte Corporation

INDUSTRY